BSE filing, BSE: 519439. Summary written from the filing by ALFA Finder's alert engine.
More from Pioneer Agro Extracts Ltd
All →Pioneer Agro Extracts Q2 FY27 Results: Net Loss of ₹0.3 Cr
Pioneer Agro Extracts Ltd reported a net loss of ₹0.3 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.3 Cr
Pioneer Agro Extracts Board Meeting Date
Pioneer Agro Extracts has intimated a board meeting scheduled for 20 Oct 2026 to consider unaudited standalone Q1 FY27 results. No financial figures are disclosed at this stage.
Pioneer Agro Extracts Annual General Meeting
Pioneer Agro Extracts filed proceedings of its 34th AGM held on 18 September 2026. No transaction value or financial-results table was disclosed.
Pioneer Agro Extracts Other Announcement
Pioneer Agro Extracts Ltd reappointed M/s. Piyush Mahajan and Associates as Statutory Auditors for a second five-year term. The appointment remains subject to shareholder approval.
- Execution
- 5 years
Pioneer Agro Extracts Q1 FY27 Results: Net Profit ₹0.1 Cr
Pioneer Agro Extracts Ltd reported net profit of ₹0.1 Cr for Q1 FY27.
- Key figure
- Net profit ₹0.1 Cr
Pioneer Agro Extracts Board Meeting Date
Pioneer Agro Extracts Ltd has scheduled a board meeting on August 14, 2026, to consider and approve standalone unaudited financial results for the quarter ended June 30, 2026.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.